Central Energy Partners LP - Limited Partnership
US ˙ OTCPK

Introduction

This page provides a comprehensive analysis of the known insider trading history of Ian T Bothwell. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Ian T Bothwell has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
Interim CEO & CFO, Director, 10% Owner 50
US:ENGY / Central Energy Partners LP - Limited Partnership EVP, CFO & Secretary 761,440
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Ian T Bothwell. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases ENGY / Central Energy Partners LP - Limited Partnership - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in ENGY / Central Energy Partners LP - Limited Partnership. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2014-01-15 ENGY BOTHWELL IAN T 325,000 0.1100 325,000 0.1100 35,750 261 0.1811 23,108 64.64

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ENGY / Central Energy Partners LP - Limited Partnership Insider Trades
Insider Sales ENGY / Central Energy Partners LP - Limited Partnership - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in ENGY / Central Energy Partners LP - Limited Partnership. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ENGY / Central Energy Partners LP - Limited Partnership Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Ian T Bothwell as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2024-12-30 2024-12-30 4 ZEOX Zeo ScientifiX, Inc.
Series C Preferred
G - Gift 50 50
2021-11-02 2021-10-29 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
J - Other 15,000,000 148,018,726 11.28
2021-11-02 2021-10-29 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
J - Other -15,000,000 133,018,726 -10.13
2021-06-21 2021-06-17 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
S - Sale -50,000 148,018,726 -0.03 0.14 -6,900 20,426,584
2021-06-16 2021-06-16 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
S - Sale -40,000 148,068,726 -0.03 0.15 -5,840 21,618,034
2021-06-16 2021-06-16 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
S - Sale -50,000 148,108,726 -0.03 0.16 -8,050 23,845,505
2021-06-16 2021-06-15 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
S - Sale -50,000 148,158,726 -0.03 0.16 -8,000 23,705,396
2021-06-16 2021-06-14 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
S - Sale -50,000 148,208,726 -0.03 0.14 -7,000 20,749,222
2021-06-11 2021-06-11 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
S - Sale -10,000 148,258,726 -0.01 0.14 -1,400 20,756,222
2021-06-11 2021-06-11 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
S - Sale -40,000 148,268,726 -0.03 0.14 -5,400 20,016,278
2021-06-11 2021-06-10 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
S - Sale -100,000 148,308,726 -0.07 0.14 -14,000 20,763,222
2021-06-11 2021-06-10 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
S - Sale -50,000 148,408,726 -0.03 0.14 -7,100 21,074,039
2021-06-11 2021-06-09 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
S - Sale -30,000 148,458,726 -0.02 0.15 -4,500 22,268,809
2021-06-11 2021-06-09 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
S - Sale -50,000 148,488,726 -0.03 0.15 -7,350 21,827,843
2021-06-08 2021-06-08 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
S - Sale -50,000 148,538,726 -0.03 0.14 -7,150 21,241,038
2021-06-08 2021-06-08 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
S - Sale -50,000 148,538,726 -0.03 0.14 -7,150 21,241,038
2021-06-08 2021-06-07 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
S - Sale -50,000 148,638,726 -0.03 0.12 -6,200 18,431,202
2021-06-08 2021-06-07 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
S - Sale -50,000 148,688,726 -0.03 0.12 -6,150 18,288,713
2021-06-08 2021-06-04 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
S - Sale -3,864 148,738,726 0.00 0.14 -537 20,674,683
2021-06-08 2021-06-04 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
S - Sale -46,136 148,742,590 -0.03 0.14 -6,321 20,377,735
2021-06-08 2021-06-04 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
S - Sale -50,000 148,788,726 -0.03 0.14 -7,000 20,830,422
2021-06-03 2021-06-02 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
S - Sale -40,000 148,838,726 -0.03 0.16 -6,400 23,814,196
2021-06-03 2021-06-02 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
S - Sale -50,000 148,878,726 -0.03 0.17 -8,500 25,309,383
2021-06-03 2021-06-01 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
S - Sale -50,000 148,928,726 -0.03 0.19 -9,600 28,594,315
2021-05-28 2021-05-28 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
S - Sale -50,000 148,978,726 -0.03 0.18 -9,100 27,114,128
2021-05-28 2021-05-27 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
S - Sale -11,350 149,028,726 -0.01 0.18 -2,066 27,123,228
2021-05-28 2021-05-27 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
S - Sale -38,650 149,040,076 -0.03 0.18 -6,957 26,827,214
2021-05-28 2021-05-27 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
S - Sale -50,000 149,078,726 -0.03 0.18 -9,000 26,834,171
2021-05-28 2021-05-26 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
S - Sale -40,000 149,128,726 -0.03 0.19 -7,720 28,781,844
2021-05-25 2021-05-25 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
S - Sale -50,000 149,168,726 -0.03 0.20 -10,000 29,833,745
2021-05-25 2021-05-25 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
S - Sale -50,000 149,218,726 -0.03 0.19 -9,550 28,500,777
2021-05-25 2021-05-24 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
S - Sale -50,000 149,268,726 -0.03 0.18 -9,000 26,868,371
2021-05-25 2021-05-21 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
S - Sale -50,000 149,318,726 -0.03 0.18 -9,000 26,877,371
2021-05-20 2021-05-20 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
S - Sale -26,274 149,368,726 -0.02 0.19 -4,992 28,380,058
2021-05-20 2021-05-20 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
S - Sale -50,000 149,395,000 -0.03 0.19 -9,500 28,385,050
2021-05-20 2021-05-19 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
S - Sale -25,000 149,445,000 -0.02 0.20 -5,000 29,889,000
2021-05-20 2021-05-19 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
S - Sale -50,000 149,470,000 -0.03 0.24 -12,000 35,872,800
2021-05-20 2021-05-18 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
S - Sale -50,000 149,520,000 -0.03 0.22 -11,000 32,894,400
2021-05-17 2021-05-17 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
S - Sale -25,000 149,570,000 -0.02 0.20 -5,000 29,914,000
2021-05-17 2021-05-17 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
S - Sale -50,000 149,595,000 -0.03 0.21 -10,300 30,816,570
2021-05-17 2021-05-14 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
S - Sale -50,000 149,645,000 -0.03 0.24 -12,000 35,914,800
2021-05-17 2021-05-13 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
S - Sale -50,000 149,695,000 -0.03 0.27 -13,500 40,417,650
2021-05-12 2021-05-12 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
S - Sale -50,000 149,745,000 -0.03 0.26 -13,100 39,233,190
2021-05-12 2021-05-11 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
S - Sale -50,000 149,795,000 -0.03 0.35 -17,500 52,428,250
2021-05-12 2021-05-10 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
S - Sale -50,000 149,845,000 -0.03 0.27 -13,700 41,057,530
2021-05-07 2021-05-07 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
S - Sale -50,000 149,895,000 -0.03 0.26 -12,750 38,223,225
2021-05-07 2021-05-07 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
S - Sale -40,000 149,945,000 -0.03 0.26 -10,400 38,985,700
2021-05-07 2021-05-06 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
S - Sale -40,000 149,985,000 -0.03 0.26 -10,400 38,996,100
2021-05-07 2021-05-05 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
S - Sale -25,000 150,025,000 -0.02 0.28 -7,125 42,757,125
2021-05-07 2021-05-05 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
S - Sale -50,000 150,050,000 -0.03 0.30 -15,050 45,165,050
2021-05-05 2021-05-04 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
S - Sale -50,000 150,100,000 -0.03 0.42 -20,750 62,291,500
2021-05-05 2021-05-03 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
S - Sale -50,000 150,150,000 -0.03 0.25 -12,500 37,537,500
2021-04-30 2021-04-30 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
S - Sale -50,000 150,200,000 -0.03 0.45 -22,500 67,590,000
2021-04-30 2021-04-29 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
S - Sale -50,000 150,250,000 -0.03 0.45 -22,500 67,612,500
2021-04-14 2021-04-06 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
A - Award 5,000,000 150,300,000 3.44
2021-02-22 2021-02-10 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
A - Award 5,000,000 145,300,000 3.56
2021-02-22 2021-01-27 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
A - Award 5,000,000 140,300,000 3.70
2020-12-30 2020-12-21 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
A - Award 15,000,000 135,300,000 12.47
2020-12-09 2020-09-17 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
A - Award 5,000,000 120,300,000 4.34 0.03 135,000 3,248,100
2020-12-09 2020-09-03 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
A - Award 5,000,000 115,300,000 4.53 0.03 135,000 3,113,100
2020-12-09 2020-08-25 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
A - Award 5,000,000 110,300,000 4.75 0.03 135,000 2,978,100
2020-09-30 2020-09-23 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
A - Award 7,000,000 105,300,000 7.12 0.28 1,960,000 29,484,000
2020-09-18 2020-08-27 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
A - Award 15,000,000 98,300,000 18.01 0.18 2,685,000 17,595,700
2020-09-18 2020-05-29 4/A BPSR Organicell Regenerative Medicine, Inc.
Common Stock
A - Award 5,000,000 83,300,000 6.39 0.08 425,000 7,080,500
2020-08-06 2020-05-29 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
A - Award 500,000 83,300,000 0.60 0.08 42,500 7,080,500
2020-08-06 2020-05-15 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
A - Award 10,000,000 78,300,000 14.64 0.04 400,000 3,132,000
2020-08-06 2020-05-01 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
A - Award 13,000,000 68,300,000 23.51 0.03 403,000 2,117,300
2020-03-17 2020-02-26 4 BPSR Organicell Regenerative Medicine, Inc.
Warrant
A - Award 7,500,000 7,500,000
2018-08-08 2018-04-23 4 BPSR Organicell Regenerative Medicine, Inc.
Warrant
X - Other -53,300,000 0 -100.00
2018-08-08 2018-04-23 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
A - Award 4,675,439 55,300,000 9.24 0.00 4,675 55,300
2018-08-08 2018-04-06 4 BPSR Organicell Regenerative Medicine, Inc.
Common Stock
A - Award 1,000,000 2,000,000 100.00 0.00 3,000 6,000
2017-04-05 2017-04-03 4 BPSR Biotech Products Services & Research, Inc.
Common Stock
A - Award 1,000,000 1,000,000 0.02 19,000 19,000
2017-03-13 2017-03-08 4 BPSR Biotech Products Services & Research, Inc.
Warrant (right to purchase)
A - Award 21,500,000 21,500,000
2017-03-13 2017-03-08 4 BPSR Biotech Products Services & Research, Inc.
Series A Non-Convertible Preferred Stock
A - Award 100 100
2014-03-19 2014-01-15 4/A ENGY CENTRAL ENERGY PARTNERS LP
Common Units
P - Purchase 325,000 761,440 74.47 0.11 35,750 83,758
2014-03-19 2013-11-20 4/A ENGY CENTRAL ENERGY PARTNERS LP
Common Units
A - Award 200,000 436,440 84.59 0.10 20,000 43,644
2014-03-19 2013-11-18 4/A ENGY CENTRAL ENERGY PARTNERS LP
Common Units
J - Other 197,628 236,440 509.19 0.11 21,739 26,008
2014-03-19 2008-03-07 4/A ENGY CENTRAL ENERGY PARTNERS LP
Common Units
A - Award 8,812 38,812 29.37 13.87 122,222 538,322
2014-03-19 2007-06-29 4/A ENGY CENTRAL ENERGY PARTNERS LP
Common Units
A - Award 25,000 25,000 11.21 280,250 280,250
2014-03-19 2007-06-07 4/A ENGY CENTRAL ENERGY PARTNERS LP
Common Units
G - Gift 5,000 5,000 10.25 51,250 51,250
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)